These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37739428)

  • 1. Health MOTs: consider reference change values.
    Flowers KC; Moore R; Wood R
    BMJ; 2023 Sep; 382():2175. PubMed ID: 37739428
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of MOTS-c in the regulation of bone metabolism.
    Yi X; Hu G; Yang Y; Li J; Jin J; Chang B
    Front Physiol; 2023; 14():1149120. PubMed ID: 37200834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a mass spectrometry based detection method for the mitochondrion-derived peptide MOTS-c in plasma samples for doping control purposes.
    Knoop A; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2019 Feb; 33(4):371-380. PubMed ID: 30394592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adropin and MOTS-c as new peptides: Do levels change in neurodegenerative diseases and ischemic stroke?
    Saçmacı H; Çakır M; Özcan SS
    J Biochem Mol Toxicol; 2023 Feb; 37(2):e23246. PubMed ID: 36303331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Serum Mitochondrial Open Reading Frame of the 12S rRNA-c (MOTS-c) Levels in Patients With Multiple Sclerosis and Healthy Controls.
    Tekin S; Bir LS; Avci E; Şenol H; Tekin I; Çınkır U
    Cureus; 2022 Jul; 14(7):e26981. PubMed ID: 35989823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intracerebroventricular MOTS-c infusion on thyroid hormones and uncoupling proteins.
    Bahar MR; Tekin S; Beytur A; Onalan EE; Ozyalin F; Colak C; Sandal S
    Biol Futur; 2023 Jun; 74(1-2):159-170. PubMed ID: 37067760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MOTS-c Functionally Prevents Metabolic Disorders.
    Gao Y; Wei X; Wei P; Lu H; Zhong L; Tan J; Liu H; Liu Z
    Metabolites; 2023 Jan; 13(1):. PubMed ID: 36677050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOTS-c repairs myocardial damage by inhibiting the CCN1/ERK1/2/EGR1 pathway in diabetic rats.
    Wang M; Wang G; Pang X; Ma J; Yuan J; Pan Y; Fu Y; Laher I; Li S
    Front Nutr; 2022; 9():1060684. PubMed ID: 36687680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases.
    Mohtashami Z; Singh MK; Salimiaghdam N; Ozgul M; Kenney MC
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.
    Zheng Y; Wei Z; Wang T
    Front Endocrinol (Lausanne); 2023; 14():1120533. PubMed ID: 36761202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOTS-c as a predictor of coronary lesions and complexity in patients with stable coronary artery disease.
    Yaşar E; Çakmak T; Bayramoğlu A; Karakuş Y; Tekin S; Şekerci G; Türkoğlu C
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5676-5682. PubMed ID: 36066139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum MOTS-C Levels are Decreased in Obese Children and Associated with Vascular Endothelial Function.
    Luo YH; Xie L; Li JY; Xie Y; Li MQ; Zhou L
    Diabetes Metab Syndr Obes; 2023; 16():1013-1020. PubMed ID: 37077579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitochondrial-derived peptide MOTS-c is a regulator of plasma metabolites and enhances insulin sensitivity.
    Kim SJ; Miller B; Mehta HH; Xiao J; Wan J; Arpawong TE; Yen K; Cohen P
    Physiol Rep; 2019 Jul; 7(13):e14171. PubMed ID: 31293078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of MOTS-c in patients with breast cancer treated with metformin.
    Cuyàs E; Verdura S; Martin-Castillo B; Menendez JA;
    Aging (Albany NY); 2022 Dec; 15(4):892-897. PubMed ID: 36490309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats.
    Li S; Wang M; Ma J; Pang X; Yuan J; Pan Y; Fu Y; Laher I
    Front Endocrinol (Lausanne); 2022; 13():812032. PubMed ID: 35370955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation.
    Ming W; Lu G; Xin S; Huanyu L; Yinghao J; Xiaoying L; Chengming X; Banjun R; Li W; Zifan L
    Biochem Biophys Res Commun; 2016 Aug; 476(4):412-419. PubMed ID: 27237975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Serum Humanin and MOTS-c Peptide Levels in Patients with COVID-19 and Healthy Subjects.
    Saracaloglu A; Mete AÖ; Ucar DF; Demiryürek S; Erbagcı E; Demiryürek AT
    Curr Protein Pept Sci; 2023; 24(3):277-283. PubMed ID: 36799414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial derived peptide MOTS-c prevents the development of heart failure under pressure overload conditions in mice.
    Zhong P; Peng J; Hu Y; Zhang J; Shen C
    J Cell Mol Med; 2022 Nov; 26(21):5369-5378. PubMed ID: 36156853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOTS-c promotes muscle differentiation in vitro.
    García-Benlloch S; Revert-Ros F; Blesa JR; Alis R
    Peptides; 2022 Sep; 155():170840. PubMed ID: 35842023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial-derived peptide MOTS-c promotes homeostasis in aged human placenta-derived mesenchymal stem cells in vitro.
    Yu WD; Kim YJ; Cho MJ; Seok J; Kim GJ; Lee CH; Ko JJ; Kim YS; Lee JH
    Mitochondrion; 2021 May; 58():135-146. PubMed ID: 33639272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.